Add to Favorites Newsroom RSS Share
fb-shareDana-Farber Cancer Institute
Boston, MA USA

Our News on Newswise

Drug combination may become new standard treatment for advanced kidney cancer

A combination of two drugs – one of them an immunotherapy agent – could become a new standard, first-line treatment for patients with metastatic kidney cancer, says an investigator from Dana-Farber Cancer Institute, reporting results from a...
15-Feb-2019 2:05 PM EST Add to Favorites

Study Finds Upsurge in ‘Active Surveillance’ for Low-Risk Prostate Cancer

Many men with low-risk prostate cancer who most likely previously would have undergone immediate surgery or radiation are now adopting a more conservative “active surveillance” strategy, according to an analysis of a new federal database by...
11-Feb-2019 8:55 AM EST Add to Favorites

Personalized vaccine to be tested for the first time in patients with kidney cancer

By pairing a novel personalized cancer vaccine with a more established immunotherapy drug that is administered to patients in an innovative fashion, scientists at Dana-Farber Cancer Institute are testing a first-of-its-kind strategy aimed at...
7-Jan-2019 9:45 AM EST Add to Favorites

David_Reardon_SOG_8071_15.jpg

Neoantigen vaccine spurs immune response in glioblastoma

In a report published in Nature, however, scientists at Dana-Farber Cancer Institute say they have shown that a personalized ‘neoantigen’ vaccine can spur a response against glioblastoma, with immune T-cells generated by the vaccine migrating...
19-Dec-2018 11:00 AM EST Add to Favorites

James Terwilliger named as Executive Vice President and Chief Operating Officer at Dana-Farber Cancer Institute

New Executive Vice President and Chief Operating Officer named at Dana-Farber Cancer Institute
18-Dec-2018 1:00 PM EST Add to Favorites

Prostate cancer scoring method may underestimate mortality risk in black men

Black men diagnosed with prostate cancer classified as low risk may actually have a more aggressive form of the disease that is more likely to be fatal than in nonblack men placed in the same prognostic category, a new study suggests.
17-Dec-2018 2:05 PM EST Add to Favorites

Dana-Farber Scientists to Present Research on Myeloma Progression From Precursor Conditions and Novel Approaches to Treatment

Dana-Farber Cancer Institute scientists will present research marking significant advances against the hematologic cancer multiple myeloma at the ASH Annual Meeting.
3-Dec-2018 10:30 AM EST Add to Favorites

Dana-Farber Scientists to Present New Research on Improving Outcomes in Stem Cell Transplantation for Myeloid Cancers

Improving outcomes for patients with myeloid cancers who undergo stem cell transplantation is a focus of several studies to be presented by Dana-Farber Cancer Institute scientists at the ASH Annual Meeting.
3-Dec-2018 6:30 PM EST Add to Favorites


see all news

Our Experts on Newswise

Dr.JeffreyMeyerhardtFINAL.jpg

Colorectal Cancer: Five Things You Need To Know

With March marking Colorectal Cancer Awareness Month, here are the answers to some key questions about Colon cancer.
5-Mar-2014 5:00 PM EST

AnnPartridge.jpg

Leading Breast Cancer Expert Available to Comment on Young Women with Breast Cancer

11-Nov-2013 5:00 PM EST

PF_SOG_7837.jpg

National Cancer Report Underscores Need for Research Funding; Dana-Farber Expert Says Scientific Advances Merit Support

17-Sep-2013 3:00 PM EDT

Dr.Haddadphoto.jpg

Vaccinating Children Against HPV?

The Human papillomavirus, or HPV, and its link to certain cancers has been in the headlines recently, reigniting the debate whether it is appropriate to vaccinate children against the virus. Robert Haddad, MD, the disease center lead at...
7-Jun-2013 12:00 PM EDT

Andrea_Patenaude.jpg

Prophylactic Double Mastectomy: Angelina Makes a Private Choice a Public Issue

24-May-2013 3:00 PM EDT

Carlos_Rodriguez-Galindo_SOG_6619_09.jpg

News Tip: New Research on Teenage Girls and Melanoma Makes This the Season for Tanning Stories

Prom season and summer approach, and with them teenage girls seeking suntans. New research published in the May issue of Pediatrics finds that the number of children diagnosed with melanoma has increased an average 2% a year since the 1970s.
17-May-2013 8:00 AM EDT

Healthy Holiday Helpings: Experts Offer Tips to Fight Cancer with Your Fork This Holiday Season

The holidays are almost here and festive food is everywhere. “While these foods are delicious to eat, some have the added bonus of containing cancer-preventing nutrients,” says Stephanie Meyers, MS, RD/LDN, a nutritionist at Dana-Farber Cancer...
23-Oct-2009 1:00 PM EDT

see all experts

Our YouTube Videos

About

The mission of Dana-Farber Cancer Institute is to provide expert, compassionate care to children and adults with cancer while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases. As an affiliate of Harvard Medical School and a Comprehensive Cancer Center designated by the National Cancer Institute, the Institute also provides training for new generations of physicians and scientists, designs programs that promote public health particularly among high-risk and underserved populations, and disseminates innovative patient therapies and scientific discoveries to our target community across the United States and throughout the world.

Contacts

Ellen Berlin
Media Relations Director

ellen_berlin@dfci.harvard.edu

617-632-5357

Irene Sege
Senior Media Relations Specialist
pediatric oncology

irene_sege@dfci.harvard.edu

617-919-7379

Robert Levy
Science Writer

robert_levy@dfci.harvard.edu

617-632-4090

Molly McHale
Associate Director for Communications

molly_mchale@dfci.harvard.edu

617-632-5675

Richard Saltus
Senior Science Writer

richard_saltus@dfci.harvard.edu

617-632-5643

Erin Podolak
Science Writer

erine_podolak@dfci.harvard.edu

617-632-6527

Donna Walthall
Marketing Director

donna_walthall@dfci.harvard.edu

617-632-5856

Peter Cohenno
Senior Media Relations Specialist

Peter_Cohenno@dfci.harvard.edu

Claire Monaghan
Senior Media Relations Specialist
hematology

Claire_Monaghan@dfci.harvard.edu

617-632-5653

John Noble
Senior Media Relations Specialist
Health Care

johnw_noble@dfci.harvard.edu

617-632-5784

Quincey Spagnoletti
Media Relations Specialist

quinceym_spagnoletti@dfci.harvard.edu

315-720-2715

Victoria Warren
Media Relations Manager

Victoria_Warren@dfci.harvard.edu

617-582-9323

Twitter twitter-icon

Chat now!